Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lab21 Acquires Business and Assets of Delphic Diagnostics

By LabMedica International staff writers
Posted on 04 Dec 2009
Lab21, (Cambridge, UK) the healthcare diagnostics company, has acquired business and assets of Delphic Diagnostics (London, UK), a specialist laboratory services business with expertise in human immunodeficiency virus (HIV) and hepatitis. More...
The financial details of the acquisition have not been disclosed.

Delphic's business is focused on personalized medicine and companion diagnostics. It has developed a world leading expertise in pharmacology, virology, therapeutic drug monitoring, and specialist clinical trial services to the pharmaceutical industry. It has laboratories in Liverpool and in Kent and partner laboratories across Europe. It has strong quality accreditations, with more than 200 National Health Service (NHS; UK) customers and partnerships with various global pharmaceutical manufacturers.

Graham Mullis, CEO of Lab21, commented, "This acquisition is highly complementary to Lab21's existing business in companion diagnostics, and significantly extends our laboratory capacity and service offering in virology." Mr. Mullis added, "This acquisition is the latest step in our buy-and-build strategy and reinforces our market leadership position in molecular diagnostic services in the UK, specifically in the rapidly growing market for companion diagnostics."

Lab21 supplies tests and services across a broad range including pharmacogenetic tests, gold-standard viral diagnostics, cytochrome P450 genotyping, and viral resistance mapping

Related Links:
Lab21
Delphic Diagnostics


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.